Gene Query: TBC1D20

Dataset Description Geneva Score
Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer (FFPE RNA-Seq II) 235.05
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 28.16
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 28.16
Gene expression changes after LOC550643 silencing 27.56
Region-specific Innate Antiviral Responses of the Human Epididymis 19.58
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 19.02
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 18.97
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 18.6
Illumina Total RNA-seq in HeLa 17.16
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 16.48
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 15.74
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 14.96
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 14.89
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 14.33
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 14.21
Developmental stage specific chromosome architecture in human erythroid cells 13.71
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 13.71
Ebola virus (EBOV) infection of ARPE-19 cells 13.42
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 13.31
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 13.03
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 13.03
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 12.61
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 12.61
Total RNA-seq in ALL-SIL upon JQ1 inhibition 12.44
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 12.22
Effect of disulfiram treatment on pediatric high grade glioma 12.09
Gene expression changes upon drug withdrawal (Mel888 cell line) 11.98
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 11.93
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 11.86
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 11.75
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 11.74
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 11.49
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 11.43
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 11.33
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 11.33
Identification of global XBP1s target gene expression in human prostate cancer cells 11.02
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 10.61
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 10.61
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 10.53
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 10.02
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 10.0
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 9.95
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 9.92
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 9.92
Selective suppression of endothelial cytokine production by progesterone receptor 9.82
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 9.82
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 9.81
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 9.78
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 9.71
A549 cells and MSR-A549 cells 9.6
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 9.6
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 9.49
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 9.25
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 9.22
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 9.17
HNF1 regulates critical functions of the human epididymis epithelium. 9.17
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 9.17
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 9.05
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 8.96
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 8.85
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 8.76
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 8.6
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 8.6
The effect of PPARG inhibition on human angiomyolipoma cells 8.58
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 8.41
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 8.38
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 8.38
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 8.26
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 8.13
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 8.13
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 8.11
HNRNPL and its RNA Targets in Prostate Cancer 8.11
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 8.08
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 8.08
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 7.97
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 7.82
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 7.75
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 7.72
MYCi361 regulates MYC target genes 7.66
RNA-seq of tumor cells following angiopellosis extravasation 7.62
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 7.55
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 7.55
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 7.5
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 7.48
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 7.47
Control of prostate tumour growth by the long non-coding RNA GHSROS 7.47
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 7.41
SLIGRL-induced gene expression changes in NHEK cells 7.38
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 7.38
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 7.36
Genetic-to-epigenetic Therapy for Pancreatic Cancer 7.36
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 7.34
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 7.3
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 7.2
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 7.14
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 7.1
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 7.08
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 7.08
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 7.08
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 6.94
Gene expression in GBM with Cav3.2 inhibition 6.9
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 6.9
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.9
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.9
Transcriptome analysis of U87 cells upon LINC00152 knockdown 6.89
Overexpression and knockdown experiment for circCSNK1G3 6.83
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 6.75
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 6.72
LINE-2 transposable elements are a source of functional human microRNAs and target sites 6.67
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 6.64
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 6.63
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 6.63
LncRNA-GAS5 negative regulation of YAP-target genes expression 6.63
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 6.62
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 6.6
Co-regulation of splicing by Rbfox1 and hnRNP M 6.6
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 6.56
Chromatin-informed inference of transcriptional programs in gynecologic cancers 6.53
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 6.53
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 6.5
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 6.49
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 6.49
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 6.48
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 6.45
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 6.45
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 6.44
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 6.38
LNCaP treated with iBET 6.34
Effect of mitochondria deficiency on senescence-associated gene expression 6.34
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 6.27
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 6.23
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 6.14
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 6.04
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 6.04
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 5.9
Landscape and variation of RNA secondary structure across the human transcriptome 5.9
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 5.85
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 5.78
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 5.78
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 5.77
Characterization of parental and rociletinib-resistant derived H1975 cell lines 5.74
mRNA recovered upon RNF219 IP. [RNA-IP] 5.73
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 5.73
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 5.72
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 5.7
RNA-seq of young and quiescent MRC-5 human fibroblasts 5.7
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 5.69
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 5.69
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 5.63
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 5.62
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 5.59
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 5.56
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 5.55
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 5.53
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 5.52
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 5.49
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 5.49
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 5.48
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 5.45
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 5.4
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 5.4
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 5.4
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 5.39
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 5.38
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 5.37
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 5.35
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 5.33
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 5.32
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 5.31
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 5.31
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 5.28
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 5.25
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 5.23
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 5.2
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 5.19
Identifying the molecular mode of action of itraconazole in colorectal cancer 5.18
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 5.18
Genome wide expression change by RNF168 knocking down in MCF-7 cells 5.18
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 5.11
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 5.11
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 5.07
In situ CAPTURE of chromatin interactions by biotinylated dCas9 5.07
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 5.07
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 5.06
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 5.06
The pause-initiation limit restricts transcription activation in human cells 5.04
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 5.04
iPSC-Derived Cholangiocytes 5.04
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 5.03
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 5.03
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 5.0
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 4.95
X-Ray induced DNA-Hydroxymethylation changes 4.94
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 4.94
ETV7 and interferon response 4.91
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 4.91
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 4.89
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 4.88
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 4.88
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 4.87
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 4.84
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 4.83
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 4.81
Transcriptional effect of ETV1 knockdown in melanoma cells 4.79
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 4.79
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 4.79
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 4.78
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 4.78
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 4.77
High-efficiency RNA-based reprogramming of human primary fibroblasts 4.77
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 4.71
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 4.71
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 4.71
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 4.7
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 4.68
Identification of Sin3B regulated genes during quiescence 4.67
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 4.66
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 4.65
MYCi975 regulates MYC target genes 4.65
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 4.63
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 4.62
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 4.61
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 4.6
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 4.6
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 4.58
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 4.58
RNA-seq of resting and activated CD4+ T cells +-JQ1 4.53
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 4.53
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 4.53
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 4.51
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.51
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 4.51
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 4.51
Genome wide expression change by RNF168 knocking down in NEC cells 4.51
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 4.49
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 4.49
Energy Metabolism during Anchorage-Independence 4.48
Effect of drugs on transcriptomic profiles 4.48
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 4.48
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 4.47
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 4.46
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 4.45
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 4.44
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 4.44
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 4.43
MEIS1 regulates hematopoiesis in hPSCs 4.42
U1 snRNP telescripting regulates size-function stratified human genome 4.41
High-Throughput Kinetic Analysis of Fractional Killing 4.39
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 4.38
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 4.38
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 4.37
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 4.33
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 4.33
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 4.33
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 4.33
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 4.3
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 4.3
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 4.3
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 4.29
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 4.28
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 4.28
Generation of KRAS signatures using immortalized isogenic lung cells. 4.27
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 4.24
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 4.24
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 4.21
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 4.21
mRNA expression profile of Lymphocytes by high-throuput sequencing 4.2
Gene expression changes in human melanoma cell lines compared to primary melanocytes 4.18
RNA-sequencing 4.15
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 4.14
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 4.11
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 4.11
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 4.1
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 4.1
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 4.1
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 4.1
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 4.03
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 4.01
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 3.97
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 3.95
miR941 overexpression experiment 3.94
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.91
U2AF1 mutations alter splice site recognition in hematological malignancies 3.9
RNAseq of T-ALL upon long non coding rna purturbation 3.89
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 3.87
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 3.83
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 3.83
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 3.82
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 3.82
RNA Seq of HMVEC under hypoxia 3.81
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 3.81
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 3.73
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 3.72
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 3.71
RNA-seq analysis of differentiating human erythroblasts 3.7
KLF6-dependent transcription in renal cancer cells 3.7
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 3.68
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 3.62
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 3.61
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 3.58
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 3.57
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 3.55
Transcriptome analyses of human pancreatic islets and pseudoislets 3.54
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 3.53
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 3.52
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 3.5
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 3.5
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 3.48
Transciptomic profiling of human fetal lung samples 3.47
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 3.43
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 3.43
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 3.42
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.4
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 3.4
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.35
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 3.35
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 3.33
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 3.3
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 3.3
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 3.3
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 3.28
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 3.27
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 3.23
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 3.21
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 3.21
Finding missing proteins from epigenetically manipulated human cells 3.19
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 3.17
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 3.16
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 3.12
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 3.12
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 3.05
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 3.05
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 3.04
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 3.04
UV_24h_GRO-Seq 3.03
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 3.03
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 3.03
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 3.01
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 2.96
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 2.95
RNA-Seq analysis of human colorectal cancer with liver metastasis 2.95
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 2.95
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 2.95
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.94
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 2.94
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 2.93
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 2.91
RNA-seq analysis of uveal melanoma cells treated with FR900359 2.9
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 2.9
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.9
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.9
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 2.85
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 2.85
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 2.85
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 2.85
Human HAP1 cells before and after nutrient deprivation 2.84
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 2.84
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 2.84
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 2.83
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 2.79
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 2.75
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 2.75
RNA-seq of RKO cells with cTAZ KO or putback 2.74
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 2.7
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 2.67
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.59
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 2.59
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 2.57
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 2.49
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 2.46
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 2.45
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 2.44
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 2.43
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.42
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 2.39
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.39
The circadian transcriptional landscape in primary human mammary epithelial cells 2.37
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 2.33
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.3
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 2.3
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 2.3
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 2.19
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 2.15
Determining mRNA half-lives on a transcriptome-wide scale 2.11
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 2.08
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 2.08
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.03
The bromodomain protein BRD4 regulates splicing during heat shock 2.02
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 2.01
Role of FGFR1 in neuronal devlopment 1.99
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.94
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 1.94
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 1.94
DRB/GRO-Seq -/+ UV 1.91
Proteomics identifies a marker signature of MAPKi resistance in melanoma 1.9
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.9
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 1.87
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 1.87
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 1.87
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.87
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 1.86
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 1.86
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 1.85
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 1.83
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 1.82
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.81
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 1.8
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 1.79
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 1.79
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.76
Targeting MTHFD2 in Acute Myeloid Leukemia 1.76
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.75
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 1.7
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 1.63
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 1.6
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 1.6
The MEF2B Regulatory Network - RNA-seq data 1.58
The MEF2B Regulatory Network 1.58
ARID1A and ARID1B loss in HCT116 cells 1.53
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.51
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.48
Conservative alteration of chromosomal expression pattern across human solid tumor types 1.44
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 1.41
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.41
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.4
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.4
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.4
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 1.36
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 1.33
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 1.33
Gene expression changes due to PARP knockdown in human cells 1.31
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.25
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.23
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 1.22
Functional significance of the HIV-1 Tat signature amino acid residues 1.2
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 1.16
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.15
Function and hormonal regulation of GATA3 in human first trimester placentation 1.13
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 1.12
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.04
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.04
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.02
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 1.02
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 1.02
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.96
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.9
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.88
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.88
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.87
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.86
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.85
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 0.85
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 0.83
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 0.83
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.76
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.76
Human Treg IFNg/IL-10 subpopulations 0.74
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.71
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.71
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 0.7
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 0.7
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.68
The transcriptome and chromatin accessbility landscape of mammalian germline 0.67
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.67
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.67
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.65
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.65
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.63
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.63
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.63
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.61
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.59
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 0.56
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.42
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.42
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 0.37
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 0.36
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.35
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.31
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.3
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 0.3
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.29
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.25
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.21
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.19
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.17
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.15
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 0.13
Deep RNA sequencing of the human placental transcriptome 0.13
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 0.11
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.1
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.1
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 0.08
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.08
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.06
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.06
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.05
Small-molecule targeting of brachyury transcription factor addiction in chordoma 0.03
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.03
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation